Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 4618 participants.
Also called NCT04297592
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 4,618 participants
- Sponsor
- Registry
-
NCT04297592
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT04297592. Randomized; no masking; primary purpose prevention. Start 2020-06-11 (actual); primary completion 2027-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
- Condition
- Infections Joint Prosthetic
- Condition
- Overweight or Obesity
- Condition
- MSSA Colonization
- Condition
- MRSA
- Condition
- Chronic Kidney Diseases
- Condition
- Diabetes
- Condition
- Autoimmune Diseases
- Condition
- Inflammatory Disease
- Condition
- Tobacco Use
- Intervention (Drug)
- Cephalexin
- Intervention (Drug)
- Doxycycline
- Intervention (Drug)
- Cefadroxil
- Lead sponsor
- Mayo Clinic
Record details
- Record id
cardio:ct-nct04297592- Content hash
4f30871d6a7559910df29c2efe88516a7a59c94e730d2a316f444bfa653d800e